Japan’s MEXT To Focus On Cancer Research
This article was originally published in PharmAsia News
Executive Summary
MEXT Japan has decided to separate some areas of business from the Atomic Energy Agency, and plans to integrate this section with the National Institute of Radiological Sciences, NIRS, to form a new corporation for cancer research by April 2015.